Sign in

CIK 0001367644

  • Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
141902018
Phone
+1 240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$145,792
in 2 filings, $146K under 10b5-1 plans

Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-04-29 Lowry Simon C SVP, R&D, CMO Grant or award +100,111 177,914
2026-03-05 Lowry Simon C SVP, R&D, CMO Shares withheld for taxes −10,636 $8.44 $90K 77,803
2026-03-03 Lowry Simon C SVP, R&D, CMO Grant or award · Employee Stock Option (Right to buy) +44,834 147,833
2025-12-14 Lowry Simon C SVP, R&D, CMO Shares withheld for taxes −3,543 $11.41 $40K 88,439
2025-03-06 Lowry Simon C SVP, R&D, CMO Grant or award +62,500 91,982
2025-03-06 Lowry Simon C SVP, R&D, CMO Grant or award · Employee Stock Options (Right to Buy) +62,500 102,999
2024-12-15 Lowry Simon C SVP, R&D, CMO Grant or award +29,482 29,482
2024-12-15 Lowry Simon C SVP, R&D, CMO Grant or award · Employee Stock Option (Right to buy) +40,499 40,499

Page 1 of 1 · 8 trades